ALPINE WOODS CAPITAL INVESTORS, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPINE WOODS CAPITAL INVESTORS, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$631,000
-33.6%
38,000
-2.6%
0.07%
-32.3%
Q2 2021$951,000
-5.5%
39,0000.0%0.10%
-11.6%
Q1 2021$1,006,000
-51.8%
39,0000.0%0.11%
-55.9%
Q4 2020$2,085,000
+29.6%
39,0000.0%0.25%
+4.5%
Q3 2020$1,609,000
-14.9%
39,0000.0%0.24%
-33.2%
Q2 2020$1,890,000
+14.7%
39,0000.0%0.36%
-0.8%
Q1 2020$1,648,000
-1.2%
39,0000.0%0.37%
+15.8%
Q4 2019$1,668,000
+18.8%
39,0000.0%0.32%
+22.4%
Q3 2019$1,404,000
+7.2%
39,000
-20.4%
0.26%
-4.8%
Q2 2019$1,310,000
-14.4%
49,000
-14.0%
0.27%
-18.3%
Q1 2019$1,530,000
+65.9%
57,000
-0.0%
0.33%
+50.7%
Q4 2018$922,000
-22.1%
57,0100.0%0.22%
-9.1%
Q3 2018$1,184,000
+149.8%
57,010
+83.8%
0.24%
+135.9%
Q2 2018$474,000
-18.8%
31,010
+19.3%
0.10%
+232.3%
Q1 2018$584,000
-7.6%
26,000
+23.8%
0.03%
-3.1%
Q4 2017$632,000
+52.7%
21,000
+90.9%
0.03%
+52.4%
Q3 2017$414,00011,0000.02%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders